Announcements Trials

Browse Landscape

Phase

Status

Recruiting 6 Terminated 1 Suspended 1 Not yet recruiting 1 Available 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Glioma 1 Glioblastoma 1

Interventions

Specimen Handling 57 Magnetic Resonance Spectroscopy 39 Carboplatin 32 Cyclophosphamide 29 Gemcitabine 28 Bevacizumab 24 pembrolizumab 23 Cisplatin 23 Biopsy 23 Paclitaxel 22 Standard of Care 21 Radiotherapy 21 Drug Therapy 21 fludarabine 20 Injections 20 Capecitabine 20 venetoclax 19 Oxaliplatin 19 Nivolumab 18 Interviews as Topic 17 toripalimab 16 Dexamethasone 16 Blood Specimen Collection 16 Radiosurgery 14 tislelizumab 13 cemiplimab 13 anlotinib 13 Azacitidine 13 Pemetrexed 12 Irinotecan 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × mirdametinib × 90 days × Clear all

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡